Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
AstraZeneca
Biotech
AstraZeneca preps new COVID push after antibody's ph. 3 success
While AstraZeneca’s COVID vaccine is leaving the scene, the British pharma is hoping it will be taking a fresh therapeutic option to regulators soon.
James Waldron
May 16, 2024 7:15am
AstraZeneca drops GOLDILOX and the porcupine in R&D update
Apr 25, 2024 3:24am
Biopharma M&A more than doubled in Q1 compared to a year ago
Apr 18, 2024 9:46am
AACR: AstraZeneca PARP inhibitor gives 'bang for your buck'
Apr 9, 2024 5:00am
AACR: Dogs, smoothies and AstraZeneca's nap-worthy carpet
Apr 8, 2024 5:00am
AstraZeneca melds with Fusion in $2B radiopharma buyout
Mar 19, 2024 5:52am